Repeated anabolic androgenic steroid treatment causes antidepressant-reversible alterations of the hypothalamic - pituitary - adrenal axis, BDNF levels and behavior

Neuropharmacology

Volumn 58, Issue 7, 2010, Pages 1078-1084

  Matrisciano, Francesco ^a,b   Modafferi, Antonella M E ^a   Togna, Giuseppina I ^a   Barone, Ylenia ^a   Pinna, Graziano ^b   Nicoletti, Ferdinando ^a,c   Scaccianoce, Sergio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c IRCCS NEUROMED   (Italy)

Author keywords

Anabolic androgenic steroids; BDNF; Chlorimipramine; Corticosteroid receptors; Corticosterone; Depression

Indexed keywords

ANABOLIC AGENT; ANDROGEN; BRAIN DERIVED NEUROTROPHIC FACTOR; CLOMIPRAMINE; CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; NANDROLONE; STANOZOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DRUG EXPOSURE; FORCED SWIMMING TEST; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION; MAJOR DEPRESSION; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT;

ANABOLIC AGENTS; ANDROGENS; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BEHAVIOR, ANIMAL; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CLOMIPRAMINE; CORTICOSTERONE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; NANDROLONE; PITUITARY-ADRENAL SYSTEM; RATS; RATS, WISTAR; RECEPTORS, GLUCOCORTICOID; STANOZOLOL; STEROIDS; SUBSTANCE-RELATED DISORDERS;

EID: 77950951067     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2010.01.015     Document Type: Article

References (67)

1. Ahima R.S., Harlan R.E. Regulation of glucocorticoid receptor immunoreactivity in the rat hippocampus by androgenic-anabolic steroids. Brain Research 1992, 585:311-314.
2. Bielajew C., Konkle A.T., Kentner A.C., Baker S.L., Stewart A., Hutchins A.A., Santa-Maria Barbagallo L., Fouriezos G. Strain and gender specific effects in the forced swim test: effects of previous stress exposure. Stress 2003, 6:269-280.
3. Borsini F., Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology 1988, 94:147-160.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72:248-254.
5. Branvall K., Bogdanovic N., Korhonen L., Lindholm D. 19-Nortestosterone influences neural stem cell proliferation and neurogenesis in the rat brain. European Journal of Neuroscience 2005, 21:871-878.
6. Breuer M.E., McGinnis M.Y., Lumia A.R., Possidente B.P. Aggression in male rats receiving anabolic androgenic steroids: effects of social and environmental provocation. Hormones and Behavior 2001, 40:409-418.
7. Brown S.M., Henning S., Wellman C.L. Mild, short-term stress alters dendritic morphology in rat medial prefrontal cortex. Cerebral Cortex 2005, 15:1714-1722.
8. Carlezon W.A., Mague S.D., Andersen S.L. Enduring behavioral effects of early exposure to methylphenidate in rats. Biological Psychiatry 2003, 54:1330-1337.
9. Cavalcante W.L., Dal Pai-Silva M., Gallacci M. Effects of nandrolone decanoate on the neuromuscular junction of rats submitted to swimming. Comparative Biochemistry and Physiology - Part C: Toxicology & Pharmacology 2004, 139:219-224.
10. Clark A.S., Fast A.S. Comparison of the effects of 17 alpha-methyltestosterone, methandrostenolone, and nandrolone decanoate on the sexual behavior of castrated male rats. Behavioral Neuroscience 1996, 110:1478-1486.
11. Cryan J.F., Hoyer D., Markou A. Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. Biological Psychiatry 2003, 54:49-58.
12. Cryan J.F., Valentino R.J., Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neuroscience and Biobehavioral Reviews 2005, 29:547-569.
13. De Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocrine Reviews 1998, 19:269-301.
14. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Archives of General Psychiatry 1997, 54:607-608.
15. Eklof A.C., Thurelius A.M., Garle M., Rane A., Sjoqvist F. The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology. European Journal of Clinical Pharmacology 2003, 59:571-577.
16. El Yacoubi M., Bouali S., Popa D., Naudon L., Leroux-Nicollet I., Hamon M., Costentin J., Adrien J., Vaugeois J.M. Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression. Proceedings of the National Academy of Sciences U S A 2003, 100:6227-6232.
17. Fernàndez-Pérez L., Flores-Morales A., Chirino-Godoy R., Diaz-Chico J.C., Diaz-Chico B.N. Steroid binding sites in liver membranes: interplay between glucocorticoids, sex steroids, and pituitary hormones. Journal of Steroid Biochemistry and Molecular Biology 2008, 109:336-343.
18. Guo Y.J., Zhang Z.J., Wang S.H., Sui Y.X., Sun Y. Notch1 signaling, hippocampal neurogenesis and behavioral responses to chronic unpredicted mild stress in adult ischemic rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009, 33:688-694.
19. Gratacòs M., Soria V., Urretavizcaya M., González J.R., Crespo J.M., Bayés M., de Cid R., Menchón J.M., Vallejo J., Estivill X. A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders. Pharmacogenomics Journal 2008, 8:101-112.
20. Gruber A.J., Pope H.G. Psychiatric and medical effects of anabolic-androgenic steroid use in women. Psychotherapy and Psychosomatics 2000, 69:19-26.
21. Hartgens F., Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Medicine 2004, 34:513-554.
22. Hunsberger J.G., Austin D.R., Chen G., Manji H.K. Cellular mechanisms underlying affective resiliency: the role of glucocorticoid receptor- and mitochondrially-mediated plasticity. Brain Research 2009, 1293:76-84.
23. Kerr J.E., Beck S.G., Handa R.J. Androgens modulate glucocorticoid receptor mRNA, but not mineralocorticoid receptor mRNA levels, in the rat hippocampus. Journal of Neuroendocrinology 1996, 8:439-447.
24. Kokras N., Antoniou K., Dalla C., Bekris S., Xagoraris M., Ovestreet D.H., Papadopoulou-Daifoti Z. Sex-related differential response to clomipramine treatment in a rat model of depression. Journal of Psychopharmacology 2009, 23:945-956.
25. Kompagne H., Bárdos G., Szénási G., Gacsályi I., Hársing L.G., Lévay G. Chronic mild stress generates clear depressive but ambiguous anxiety-like behaviour in rats. Behavioural Brain Research 2008, 193:311-314.
26. Kouri E.M., Pope H.G., Katz D.L. Use of anabolic-androgenic steroids: we are talking prevalence rates. Journal of the American Medical Association 1993, 270:1217-1221.
27. Kouvelas D., Pourzitaki C., Papazisis G., Dagklis T., Dimou K., Kraus M.M. Nandrolone abuse decreases anxiety and impairs memory in rats via central androgenic receptors. International Journal of Neuropsychopharmacology 2008, 11:925-934.
28. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
29. Kubala K.H., McGinnis M.Y., Anderson G.M., Lumia A.R. The effects of an anabolic androgenic steroid and low serotonin on social and non-social behaviors in male rats. Brain Research 2008, 1232:21-29.
30. Le Grevès P., Huang W., Johansson P., Thörnwall M., Zhou Q., Nyberg F. Effects of an anabolic-androgenic steroid on the regulation of the NMDA receptor NR1, NR2A and NR2B subunit mRNAs in brain regions of the male rat. Neuroscience Letters 1997, 226:61-64.
31. Lindqvist A.S., Johansson-Steensland P., Nyberg F., Fahlke C. Anabolic androgenic steroid affects competitive behaviour, behavioural response to ethanol and brain serotonin levels. Behavioural Brain Research 2002, 133:21-29.
32. Long S.F., Wilson M.C., Sufka K.J., Davis W.M. The effects of cocaine and nandrolone co-administration on aggression in male rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1996, 20:839-856.
33. López-León S., Janssens A.C., González-Zuloeta Ladd A.M., Del-Favero J., Claes S.J., Oostra B.A., van Duijn C.M. Meta-analyses of genetic studies on major depressive disorder. Molecular Psychiatry 2008, 13:772-785.
34. Malone D.A., Dimeff R.J., Lombardo J.A., Sample R.H. Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users. Clinical Journal of Sport Medicine 1995, 5:25-31.
35. Matrisciano F., Caruso A., Orlando R., Marchiafava M., Bruno V., Battaglia G., Gruber S.H., Melchiorri D., Tatarelli R., Girardi P., Mathè A.A., Nicoletti F. Defective group-II metaboropic glutamate receptors in the hippocampus of spontaneously depressed rats. Neuropharmacology 2008, 55:525-531.
36. Matrisciano F., Bonaccorso S., Ricciardi A., Scaccianoce S., Panaccione I., Wang L., Ruberto A., Tatarelli R., Nicoletti F., Girardi P., Shelton R.C. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. Journal of Psychiatric Research 2009, 43:247-254.
37. Mattsson C., Lai M., Noble J., McKinney E., Yau J.L., Seckl J.R., Walker B.R. Obese Zucker rats have reduced mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 1 expression in hippocampus-implications for dysregulation of the hypothalamic-pituitary-adrenal axis in obesity. Endocrinology 2003, 144:2997-3003.
38. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiological Reviews 2007, 87:873-904.
39. Menard C.S., Harlan R.E. Up-regulation of androgen receptor immunoreactivity in the rat brain by androgenic-anabolic steroids. Brain Research 1993, 622:226-236.
40. Morley-Fletcher S., Darnaudery M., Koehl M., Casolini P., Van Reeth O., Maccari S. Prenatal stress in rats predicts immobility behavior in the forced swim test. Effects of a chronic treatment with tianeptine. Brain Research 2003, 989:246-251.
41. Morley-Fletcher S., Darnaudéry M., Mocaer E., Froger N., Lanfumey L., Laviola G., Casolini P., Zuena A.R., Marzano L., Hamon M., Maccari S. Chronic treatment with imipramine reverses immobility behaviour, hippocampal corticosteroid receptors and cortical 5-HT(1A) receptor mRNA in prenatally stressed rats. Neuropharmacology 2004, 47:841-847.
42. Muigg P., Hoelzl U., Palfrader K., Neumann I., Wigger A., Landgraf R., Singewald N. Altered brain activation pattern associated with drug-induced attenuation of enhanced depression-like behavior in rats bred for high anxiety. Biological Psychiatry 2007, 61:782-796.
43. Overstreet D.H., Janowsky D.S., Gillin J.C., Shiromani P.J., Sutin E.L. Stress-induced immobility in rats with cholinergic supersensitivity. Biological Psychiatry 1986, 21:657-664.
44. Parker K.J., Schatzberg A.F., Lyons D.M. Neuroendocrine aspects of hypercortisolism in major depression. Hormones and Behavior 2003, 43:60-66.
45. Patel J.G., Bartoszyk G.D., Edwards E., Ashby C.R. The highly selective 5-hydroxytryptamine (5-HT)2A receptor antagonist, EMD 281014, significantly increases swimming and decreases immobility in male congenital learned helpless rats in the forced swim test. Synapse 2004, 52:73-75.
46. Penatti C.A., Porter D.M., Henderson L.P. Chronic exposure to anabolic androgenic steroids alters neuronal function in the mammalian forebrain via androgen receptor- and estrogen receptor-mediated mechanisms. Journal of Neuroscience 2009, 29:12484-12496.
47. Perry P.J., Kutscher E.C., Lund B.C., Yates W.R., Holman T.L., Demers L. Measures of aggression and mood changes in male weightlifters with and without androgenic anabolic steroid use. Journal of Forensic Sciences 2003, 48:646-651.
48. Pope H.G., Katz D.L. Affective and psychotic symptoms associated with anabolic steroid use. American Journal of Psychiatry 1988, 145:487-490.
49. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
50. Rasika S., Alvarez-Buylla A., Nottebohm F. BDNF mediates the effects of testosterone on the survival of new neurons in an adult brain. Neuron 1999, 22:53-62.
51. Rezvani A.H., Parsian A., Overstreet D.H. The Fawn-Hooded (FH/Wjd) rat: a genetic animal model of comorbid depression and alcoholism. Psychiatric Genetics 2002, 12:1-16.
52. Ridder S., Chourbaji S., Hellweg R., Urani A., Zacher C., Schmid W., Zink M., Hörtnagl H., Flor H., Henn F.A., Schütz G., Gass P. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. Journal of Neuroscience 2005, 25:6243-6250.
53. Roceri M., Cirulli F., Pessina C., Peretto P., Racagni G., Riva M.A. Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions. Biological Psychiatry 2004, 55:708-714.
54. Rossbach U.L.W., Steensland P., Nyberg F., Le Grevés P. Nandrolone-induced hippocampal phosphorylation of NMDA receptor subunits and ERKs. Biochemical and Biophysical Research Communications 2007, 357:1028-1033.
55. Rygula R., Abumaria N., Havemann-Reinecke U., Rüther E., Hiemke C., Zernig G., Fuchs E., Flügge G. Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepam. Behavioural Pharmacology 2008, 19:183-196.
56. Rygula R., Abumaria N., Flügge G., Fuchs E., Rüther E., Havemann-Reinecke U. Anhedonia and motivational deficits in rats: impact of chronic social stress. Behavioural Brain Research 2005, 162:127-134.
57. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Archives of General Psychiatry 2000, 57:925-935.
58. Scaccianoce S., Del Bianco P., Paolone G., Caprioli D., Modafferi A.M., Nencini P., Badiani A. Social isolation selectively reduces hippocampal brain-derived neurotrophic factor without altering plasma corticosterone. Behavioural Brain Research 2006, 168:323-325.
59. Schaaf M.J., de Jong J., de Kloet E.R., Vreugdenhil E. Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone. Brain Research 1998, 813:112-120.
60. Schlussman S.D., Zhou Y., Johansson P., Kiuru A., Ho A., Nyberg F., Kreek M.J. Effects of the androgenic anabolic steroid, nandrolone decanoate, on adrenocorticotropin hormone, corticosterone and proopiomelanocortin, corticotropin releasing factor (CRF) and CRF receptor1 mRNA levels in the hypothalamus, pituitary and amygdala of the rat. Neuroscience Letters 2000, 284:190-194.
61. Schulte-Herbrüggen O., Chourbaji S., Ridder S., Brandwein C., Gass P., Hörtnagl H., Hellweg R. Stress-resistant mice overexpressing glucocorticoid receptors display enhanced BDNF in the amygdala and hippocampus with unchanged NGF and serotonergic function. Psychoneuroendocrinology 2006, 31:1266-1277.
62. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioural models of depression. Journal of Neuroscience 2002, 22:3251-3261.
63. Smith M.A., Makino S., Kvetnansky R., Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. Journal of Neuroscience 1995, 15:1768-1777.
64. Slone J.L., Redei E.E. Maternal alcohol and adrenalectomy: asynchrony of stress response and forced swim behavior. Neurotoxicology and Teratology 2002, 24:173-178.
65. Talih F., Fattal O., Malone D. Anabolic steroid abuse: psychiatric and physical costs. Cleveland Clinic Journal of Medicine 2007, 74:341-344.
66. Tamura H., Maness S.C., Reischmann K., Dorman D.C., Gray L.E., Gaido K.W. Androgen receptor antagonism by the organophosphate insecticide fenitrothion. Toxicological Sciences 2001, 60:56-62.
67. Wang H.X., Liu X., Xu C.J., Ma X.C., Long J.E., Li D. Induction of liver cytochrome P450 1A2 expression by flutamide in rats. Acta Pharmacologica Sinica 2005, 26:1382-1386.